A Study On Assessment Of Autonomic Nervous System Function In Patients With Type 2 Diabetes Mellitus

Sharath shanmugam (1) , Oshin mantro (2) , Jagadeesan M (3) , Mariraj I (4) , Prasanna Karthik S (5) , Gowrishankar (6) , Magesh Kumar (7) , Vinoth Kanna S (8)
(1) Department of General Medicine, Saveetha Medical College and Hospital, SIMATS Thandalam Chennai, Tamilnadu – 602105, India, India ,
(2) Department of General Medicine, Saveetha Medical College and Hospital, SIMATS Thandalam Chennai, Tamilnadu – 602105, India, India ,
(3) Department of General Medicine, Saveetha Medical College and Hospital, SIMATS Thandalam Chennai, Tamilnadu – 602105, India, India ,
(4) Department of General Medicine, Saveetha Medical College and Hospital, SIMATS Thandalam Chennai, Tamilnadu – 602105, India, India ,
(5) Department of General Medicine, Saveetha Medical College and Hospital, SIMATS Thandalam Chennai, Tamilnadu – 602105, India, India ,
(6) Department of General Medicine, Saveetha Medical College and Hospital, SIMATS Thandalam Chennai, Tamilnadu – 602105, India, India ,
(7) Department of General Medicine, Saveetha Medical College and Hospital, SIMATS Thandalam Chennai, Tamilnadu – 602105, India, India ,
(8) Department of Neurology, Saveetha Medical College and Hospital, Chennai SIMATS Thandalam, Tamilnadu – 602105, India, India

Abstract

The autonomic nervous system (ANS) innervates the entire neuraxis and influences the functions of all organs. This study was undertaken for evaluating the autonomic dysfunction in diabetic patients using clinical autonomic tests and neuro- electrophysiology. A prospective study was carried out in 66 patients with type II diabetes mellitus in a tertiary care hospital for one year. Systemic examination, necessary investigations, nerve conduction study and clinical testing for the autonomic nervous system were done. The results were noted and analyzed. 65.2% were females, whereas 34.8% were males. Mean duration of diabetes was found to be 9.06 years (SD 4.121). 80.3% population was known to have type 2 diabetes for 5-10 years duration, 13.6% had diabetes for 10-15 years, and only 3.5% had diabetes for more than 15 years. Mean FBS was found to be 196.12(mg/dl) ±77.180 SD and mean PPBS was 303.26(mg/dl) ±115.385 SD. Mean HbA1c levels were 10.95 ± 2.36 SD. 33.3% showed early parasympathetic involvement for cardiac autonomic neuropathy, 9% had definite parasympathetic involvement, and only 6% had both parasympathetic and sympathetic involvement. 62.12% showed abnormal responses in nerve conduction study, of which 48.78% had autonomic dysfunction. The main factor responsible for the development and progression of autonomic dysfunction is poor glycaemic status. If contributing factors can
be detected, early identification of cardiac autonomic neuropathy (CAN) and appropriate management would halt its progression. Aggressive glycaemic monitoring and treatment shall bring down the progression and prolong the time interval in showing abnormal responses in autonomic function testing.

Full text article

Generated from XML file

References

Aggarwal, S., Tonpay, P. S., Trikha, S., Bansal, A. 2011. Prevalence of autonomic neuropathy in diabetes Mellitus. Curr Neurobiol, 2(2):101–105.

Birajdar, S. V., Chavan, S. S., Munde, S. A., Bende, Y. P. 2017. A Study of autonomic nervous system dysfunction among patient with diabetes mellitus: a cross sectional study. International Journal of Advances in Medicine, 4(2):406–406.

Chidambaram, H., Gnanamoorthy, K., Suthakaran, P. K., Rajendran, K., Pavadai, C. 2017. Assessment of autonomic dysfunction in acute stroke patients at a tertiary care hospital. Journal of clinical and diagnostic research, 11(2):28–31.

Ewing, D. J., Campbell, I. W., Murray, A., Neilson, J. M., Clarke, B. F. 1978. Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. BMJ, 1(6106):145–147.

Fisher, V. L., Tahrani, A. A. 2017. Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives. Diabetes, metabolic syndrome and obesity: targets and therapy, 10:419– 423.

Gupta, S. B., Pandit, R. B. 1992. Silent myocardial ischaemia and cardiac autonomic neuropathy in diabetics. Indian heart journal, 44(4):227–229.

John, L., Sharma, R. N., John, G., Ganesh, A. 1986. Assessment of cardiac autonomic neuropathy in type II (non-insulin-dependent) diabetic subjects. The Journal of the Association of Physicians of India, 34(4):264–267.

Nijhawan, S., Mathur, A., Singh, V., Bhandari, V. M. 1993. Autonomic and peripheral neuropathy in insulin-dependent diabetics. The Journal of the Association of Physicians of India, 41(9):565–566.

Ramachandran, A., Snehalatha, C., Kapur, A., Vijay, V., Mohan, V., Das, A. K. 2001. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia, 44(9):1094–1101.

Vinik, A. I., Erbas, T. 2001. Recognizing and treating diabetic autonomic neuropathy. Cleveland Clinic Journal of Medicine, 68(11):928–930.

Authors

Sharath shanmugam
Oshin mantro
Jagadeesan M
Mariraj I
Prasanna Karthik S
Gowrishankar
Magesh Kumar
Vinoth Kanna S
svkanna2006@yahoo.co.in (Primary Contact)
Sharath shanmugam, Oshin mantro, Jagadeesan M, Mariraj I, Prasanna Karthik S, Gowrishankar, Magesh Kumar, & Vinoth Kanna S. (2021). A Study On Assessment Of Autonomic Nervous System Function In Patients With Type 2 Diabetes Mellitus. International Journal of Research in Pharmaceutical Sciences, 12(1), 699–702. Retrieved from https://ijrps.com/home/article/view/382

Article Details

Most read articles by the same author(s)

No Related Submission Found